We are excited to launch this 4-year study, co-led by Peter Merkel at Penn and Jiang Bian at the University of Florida, to take real-world data based evidence generation to its next level of informing clinical practice and decision-making. We will use data from more than 10 health systems with 27 million patients for early detection of rare diseases.
For more information, please see: https://www.pennmedicine.org/news/news-releases/2022/september/researchers-aim-to-use-ai-to-predict-rare-diseases.